Today’s AP News (Associated Press) carried a report on the 23andMe DNA company. “Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.” Be sure to scroll down the page to read all parts of the article including this important paragraph. “Regeneron […]